Additionally, Kennedy has focused on improving health and nutrition, with unfounded claims that weight loss medications are ... In this undated stock photo, a man rests his head on a desk behind ...
Investors are scrambling to adjust, after the telehealth specialist Hims & Hers said it would stop selling an alternative to Novo Nordisk's Wegovy and Ozempic weight-loss drugs. Hims stock stood ...
Hims and Hers' stock ... hit weight loss drugs. "We will have to start notifying customers in the coming month and two that they will need to start looking for alternative options on the ...
Hims and Hers plans to stop selling compounded weight loss drugs after an FDA update. Hims and Hers' stock fell over 19 ... for alternative options on the commercial dosing," Andrew Dudum, Hims ...
Aggressive investors could find Viking Therapeutics stock appealing. There's no secret to their success: Both companies have blockbuster weight-loss drugs. But the obesity market could soon have a ...
Novo Nordisk stock is up around 75% despite a pullback in recent months. There's no secret to their success: Both companies have blockbuster weight-loss drugs. But the obesity market could soon ...
Hims & Hers makes its Super Bowl commercial debut in 2025 with a spot for the telehealth company's weight loss medications. Set to the "This Is America" by Childish Gambino (Donald Glover), the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results